P23 Procalcitonin testing in acute infection to guide antibiotic course lengths in the ICU as a tool for antibiotic stewardship
Miriam Beattie, James Donachie, Laura Stewart, Simon Gill, David Cain, Neil Powell

TL;DR
This study examines how often procalcitonin (PCT) testing is used in an ICU to guide antibiotic use, finding low adherence to protocols and limited impact on decision-making.
Contribution
The study evaluates local adherence to PCT testing protocols in an ICU for antibiotic stewardship during the post-COVID-19 period.
Findings
Only 45% of antibiotic courses had a baseline PCT test ordered.
Antibiotic courses in the ICU averaged 2.98 days, with limited PCT-guided decisions.
PCT testing was inconsistent with the proposed local algorithm.
Abstract
Procalcitonin (PCT) was introduced into the ICU during the COVID-19 pandemic. PCT enables optimization of antibiotic course lengths for ICU patients, positively impacting antimicrobial stewardship. To evaluate local adherence to PCT testing for patients with suspected acute bacterial infections in an ICU in England. Patients discharged from the ICU between 1 November and 30 November 2023 were identified. PCT test timing, frequency, PCT level, antibiotic course lengths (both in the ICU and after ICU discharge) and infection diagnosis were extracted. Adherence to a proposed local PCT testing protocol was determined and the medical notes reviewed for evidence of PCT guided antibiotic decision making. Of 65 patients discharged from ICU, 49 (75.4%) received antibiotics during their ICU stay. Thirty-six (77.6%) of these patients had 40 antibiotic courses for suspected acute bacterial…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSepsis Diagnosis and Treatment
